Inovio to present at the oppenheimer 34th annual healthcare life sciences conference

Plymouth meeting, pa. , feb. 7, 2024 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that dr. jacqueline shea, president and ceo will present at the oppenheimer 34th annual healthcare life sciences conference.
INO Ratings Summary
INO Quant Ranking